Global Insulin Delivery Devices Market Projected to Surpass $26.3 Billion by 2029 with 8.2% Annual Growth

What Are the Market Size and Growth Forecast for the Insulin Delivery Devices Market?
The market size of insulin delivery devices has seen robust growth in the recent past. The market value is anticipated to rise from $17.71 billion in 2024, reaching $19.22 billion in 2025 with an expected compound annual growth rate (CAGR) of 8.5%. The historical growth can be linked to the convenience and user-friendliness of insulin delivery devices, supportive reimbursement policies, escalating obesity rates, an increasingly aging population, and the growing popularity of insulin pumps.

Anticipated robust growth in the insulin delivery devices market is set to increase its size to $26.3 billion by 2029, with a compound annual growth rate (CAGR) of 8.2%. This expected growth during the forecasted period is associated with factors such as increasing prevalence of diabetes, rising expenditure on diabetes healthcare, emergence of continuous glucose monitoring systems, growing patient awareness of the advantages of automated insulin delivery devices, and a heightened emphasis on healthcare. The forecast period is also expected to see major shifts including technological improvements in insulin delivery devices, the merging of digital technology with these devices, the emergence of artificial pancreas systems, and advances in insulin administration techniques, and bionic technology.

What Key Elements Are Boosting Growth in the Insulin Delivery Devices Market?
The insulin delivery devices market is expected to surge due to the rising incidence of diabetes. This chronic ailment, characterized by high levels of sugar in the blood, is caused by either an insufficient production of insulin by the pancreas or by the body's inability to effectively use the insulin it produces. Sedentary lifestyles, poor dietary choices, and an increase in obesity rates worldwide are primarily contributing to the escalating rates of diabetes. To manage their blood sugar levels effectively, individuals with diabetes use insulin delivery devices that allow them to administer insulin in a manageable and convenient manner. This helps avoid complications and promotes overall health. For example, the Centers for Disease Control and Prevention, a U.S. government agency, stated in December 2022 that the number of individuals under 20 with type 2 diabetes in the United States could rachet up by nearly 700% - reaching 220,000 by 2060. Additionally, over this timeframe, diagnoses of type 1 diabetes in the youth could escalate by up to 65%. Thus, the increasing incidence of diabetes is spurring the growth of the insulin delivery devices market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18642&type=smp

Which Key Market Leaders Are Driving Insulin Delivery Devices Industry Growth?
Major companies operating in the insulin delivery devices market are Sanofi SA, Abbott Laboratories, F. Hoffmann-La Roche Ltd., Medtronic Plc, Eli Lilly and Company, Novo Nordisk A/S, Becton, Dickinson and Company, EOFlow Co. Ltd., Insulet Corporation, Tandem Diabetes Care Inc., Ypsomed Holding AG, Xeris Pharmaceuticals Inc., Beta Bionics Inc., Zealand Pharma AS, Bigfoot Biomedical Inc., Emperra GmbH, Animas Corporation, Debiotech SA, CeQur Corporation, Aerami Therapeutics Inc., Alshifa Medical Group, AMF Medical SA, Andain Inc., Avecho Biotechnology Ltd., Apex Medical Devices

What Are the Emerging Trends in the Insulin Delivery Devices Industry?
Leading firms in the insulin delivery devices sector are progressing in their introduction of innovative products like insulin pumps, aimed at providing regular or customizable insulin supply. Insulin pumps, being programmable, distribute insulin on a steady basis or as required, via a catheter inserted beneath the skin. To illustrate, Beta Bionics, an American medical tech company, received approval from the U.S. Food and Drug Administration for the iLet ACE Pump and the iLet Dosing Decision Software in May 2023. The iLet Bionic Pancreas system, designed to cater to individuals aged six and older with type 1 diabetes, marries two devices with an FDA-approved integrated continuous glucose monitor (iCGM). The automated insulin dosing (AID) system, running on a responsive closed-loop algorithm, utilizes solely the user's body weight for configuration, doing away with the need for setting additional insulin dosing parameters. Contrastingly to standard pump therapy, this system does away with manual setting adjustments, simplifying initiation and management. The iLet device integrates a meal announcement feature, which simplifies insulin dosing at meal times by classifying meals into small, medium, or large categories. The algorithm then learns and adjusts to individual insulin needs over time.

What Are the Main Segments in the Insulin Delivery Devices Market?
The insulin delivery devices market covered in this report is segmented -

1) By Type: Insulin Syringes, Insulin Jet Injectors, Pen Needles, Reusable Insulin Pens, Disposable Insulin Pens, Insulin Pumps, External Or Tethered Pumps, Patch Pumps
2) By Disease Indication: Type 1, Type 2
3) By Distribution Channels: Hospital Pharmacies, Retail Pharmacies, Online Sales, Diabetes Clinics Or Centers

Subsegments:
1) By Insulin Syringes: Standard Insulin Syringes, Insulin Syringes With Fixed Or Adjustable Needle Length
2) By Insulin Jet Injectors: Needle-Free Insulin Jet Injectors, High-Pressure Insulin Jet Injectors
3) By Pen Needles: Short Pen Needles, Long Pen Needles
4) By Reusable Insulin Pens: Reusable Pens With Replaceable Cartridges, Refillable Insulin Pens
5) By Disposable Insulin Pens: Single-Use Disposable Insulin Pens, Pre-Filled Disposable Insulin Pens
6) By Insulin Pumps: Traditional Insulin Pumps, Smart Insulin Pumps
7) By External Or Tethered Pumps: Traditional External Insulin Pumps, Wireless Tethered Pumps
8) By Patch Pumps: Patch Insulin Pumps, Integrated Patch Pumps

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/insulin-delivery-devices-global-market-report

Which Geographic Area Leads the Insulin Delivery Devices Market?
North America was the largest region in the insulin delivery devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the insulin delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Insulin Delivery Devices Global Market Report?

- Market Size Analysis: Analyze the Insulin Delivery Devices Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Insulin Delivery Devices Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Insulin Delivery Devices Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Insulin Delivery Devices Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18642

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.